High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study

High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study

Background 2018 American Heart Association/American College of Cardiology cholesterol guideline recommends statin in patients with chronic and/or stable liver disease for secondary prevention of atherosclerotic cardiovascular disease yet remains equivocal on the adequate intensity of statin for pati...

Full description

Bibliographic Details
Main Authors:	Sungho Bea, In‐Sun Oh, Ju Hwan Kim, Dong Hyun Sinn, Yoosoo Chang, Seungho Ryu, Ju‐Young Shin
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	atherosclerotic cardiovascular disease chronic liver disease epidemiology prevention statin intensity
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.028310

Similar Items

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
by: Michael M. Hammond, et al.
Published: (2023-04-01)

Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
by: Teimur Kayani, et al.
Published: (2024-03-01)

10-YEAR RISK ESTIMATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS
by: Olha M. Chernatska, et al.
Published: (2021-06-01)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
by: In Sun Ryou, et al.
Published: (2022-11-01)

Natural language processing to identify reasons for sex disparity in statin prescriptions
by: Celeste Witting, et al.
Published: (2023-06-01)

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) StudyPlain-Language Summary
by: Bharat Poudel, et al.
Published: (2021-09-01)

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease
by: Cheng Yang, et al.
Published: (2023-12-01)

Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease
by: Jong Hyun Jhee, et al.
Published: (2020-03-01)

Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas
by: Xieda Zhou, et al.
Published: (2021-07-01)

Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin‐Associated Side Effects
by: Sarah T. Ahmed, et al.
Published: (2020-11-01)

The Impact of Age on Statin-Related Glycemia: A Propensity Score-Matched Cohort Study in Korea
by: Shaopeng Xu, et al.
Published: (2022-04-01)

Evaluation of Statin Indication and Dose Intensification Among Type 2 Diabetic Patients at a Tertiary Hospital
by: Fisseha PY, et al.
Published: (2024-03-01)

Research Landscape on Atherosclerotic Cardiovascular Disease and Inflammation: A Bibliometric and Visualized Study
by: Wende Tian, et al.
Published: (2022-09-01)

Role of statins in the management of dyslipidaemia
by: Saumitra Ray
Published: (2024-03-01)

Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
by: Stanisław Surma, et al.
Published: (2021-12-01)

Residual Risk of Coronary Atherosclerotic Heart Disease and Severity of Coronary Atherosclerosis Assessed by ApoB and LDL-C in Participants With Statin Treatment: A Retrospective Cohort Study
by: Tianci Yao, et al.
Published: (2022-04-01)

The Question of a Role for Statins in Age-Related Macular Degeneration
by: Marina Roizenblatt, et al.
Published: (2018-11-01)

A microRNA Signature for the Diagnosis of Statins Intolerance
by: Alipio Mangas, et al.
Published: (2022-07-01)

Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis
by: Peter P. Toth, et al.
Published: (2019-09-01)

Incidence of cancers in patients with atherosclerotic cardiovascular diseases
by: Makoto Suzuki, et al.
Published: (2017-12-01)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
by: Christie M. Ballantyne, et al.
Published: (2022-08-01)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
by: Isabella Sudano, et al.
Published: (2022-07-01)

Statins in primary prophylaxis of cardiovascular diseases
by: Zhanna Davidovna Kobalava, et al.
Published: (2011-09-01)

The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review
by: Nikolaos PE Kadoglou, et al.
Published: (2024-01-01)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
by: Roberto Gabbiadini, et al.
Published: (2023-05-01)

STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Statin and MTHFR C677T Polymorphism in Patients with Cardiovascular Diseases
by: Muzeyyen IZMIRLI, et al.
Published: (2014-03-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Guillaume Marquis‐Gravel, et al.
Published: (2024-02-01)

Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study
by: Hyungtae Kim, et al.
Published: (2019-08-01)

The Effect of Intensive Statin Therapy on Symptomatic Intracranial Arterial Stenosis
by: Peiyang ZHOU, et al.
Published: (2018-02-01)

Holistic Approach in Follow-up of Individuals Living with HIV: Primary Cardiovascular Protection
by: Nursel ÇALIK BAŞARAN, et al.
Published: (2024-03-01)

Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity
by: Ashish Sarraju, et al.
Published: (2024-03-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Pathways by Which Food Insecurity Is Associated With Atherosclerotic Cardiovascular Disease Risk
by: Deepak Palakshappa, et al.
Published: (2021-11-01)

Atherosclerotic cardiovascular disease burden in Ghana: A scoping review
by: Francis Agyekum, et al.
Published: (2023-01-01)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
by: Kamil F. Faridi, et al.
Published: (2023-06-01)

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
by: Saket Girotra, et al.
Published: (2023-10-01)

Clinical efficacy and safety outcomes of bempedoic acid: An updated systematic review and meta-analysis after CLEAR Outcomes trial
by: Amit Bhandari, et al.
Published: (2023-12-01)

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
by: Yoichi Morofuji, et al.
Published: (2022-01-01)